Results 111 to 120 of about 3,203,567 (223)

Age- and gender-specific acute poisoning with drugs and medications affecting nervous system. [PDF]

BMC Pharmacol Toxicol
Mesgarpour B, Faridfar S, Rezaei M, Abdollahiasl A, Shadnia S, Mahdavinejad A, Abdollahi M.   +6 more
europepmc   +1 more source

Longitudinal analysis of pupillometry according to type of pharmacotherapy in Parkinson's disease patients. [PDF]

Sci Rep
Bartošová O, Dušek P, Šíma M, Stránský D, Hlaváč J, Růžička E, Šonka K, Slanař O.   +7 more
europepmc   +1 more source

The protective role of anti-parkinsonian drugs in pancreatic cancer risk: A comprehensive case-control study in Taiwan. [PDF]

Cancer Sci
Yang HC, Chou WC, Nguyen PA, Nguyen NTH, Phuong NT, Wang CH, Hsu JC, Lin MC, Huang CW.   +8 more
europepmc   +1 more source

The association between nervous system drugs and incidence of Amyotrophic Lateral Sclerosis [PDF]

, 2015
Calvo, Andrea, Chio', Adriano, D'Errico, Angelo, D'Ovidio, Fabrizio, Scarinzi, Cecilia   +4 more
core  

The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy. [PDF]

Intern Med
Okusa S, Nakahara J, Seki M.
europepmc   +1 more source

Study of autocorrelations and uncertainties applied to patients with Parkinson's disease. [PDF]

Sci Rep
Oliveira Filho FM, Dos Santos Silva EF, de Freitas Santos SE, Bandeira Santos AÁ, Zebende GF.   +4 more
europepmc   +1 more source

Predictive Value of Perivascular Space Network and Choroid Plexus for Levodopa Responsiveness in Parkinson's Disease. [PDF]

Eur J Neurol
Chen Z, Huang S, Liang Y, Cai D, Zhou X, He W, Xia J.   +6 more
europepmc   +1 more source

Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024. [PDF]

Nat Sci Sleep
Wei S, Song X, Chen R, Chen S, Lu B.
europepmc   +1 more source

Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment. [PDF]

PLoS One
Pamlényi K, Ferreira B, Regdon G, Kristó K, Sarmento B.   +4 more
europepmc   +1 more source

A 4-Year Follow-Up of Levodopa-Entacapone-Carbidopa Intestinal Gel Treatment in Parkinson's Disease. [PDF]

Mov Disord Clin Pract
Öthman M, Nyholm D.
europepmc   +1 more source